Stockscreener 앱 받기
2.70
1.12%
0.03
전일 마감가:
$2.67
열려 있는:
$2.5889
하루 거래량:
954
Relative Volume:
0.20
시가총액:
$11.14M
수익:
$33.36M
순이익/손실:
$-10.83M
주가수익비율:
-8.7097
EPS:
-0.31
순현금흐름:
$-5.54M
1주 성능:
+3.45%
1개월 성능:
+2.27%
6개월 성능:
-0.37%
1년 성능:
-40.85%
1일 변동 폭
$2.5889
$2.70
1주일 범위
$2.53
$2.7187
52주 변동 폭
$2.51
$5.90
Strata Skin Sciences Inc Stock (SSKN) Company Profile
명칭
Strata Skin Sciences Inc
전화
215-619-3200
주소
5 WALNUT GROVE DRIVE, HORSHAM, PA
SSKN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SSKN
Strata Skin Sciences Inc
|
2.69 | 11.14M | 33.36M | -10.83M | -5.54M | -0.31 |
|
ABT
Abbott Laboratories
|
131.54 | 225.32B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
99.99 | 149.74B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
376.10 | 142.48B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
88.56 | 113.49B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
71.75 | 42.10B | 5.72B | 4.17B | 259.90M | 6.97 |
Strata Skin Sciences Inc Stock (SSKN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2019-12-09 | 개시 | Ladenburg Thalmann | Buy |
| 2019-11-21 | 개시 | Oppenheimer | Outperform |
| 2018-12-10 | 개시 | Northland Capital | Outperform |
| 2017-05-16 | 재확인 | Rodman & Renshaw | Buy |
| 2017-02-21 | 재개 | Rodman & Renshaw | Buy |
Strata Skin Sciences Inc 주식(SSKN)의 최신 뉴스
STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Q4 2024 Earnings Call Transcript - MSN
STRATA Skin Sciences Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
STRATA Skin Sciences revenue up 10% to USD 9.6 million in Q4 2024 - Medical Buyer
STRATA Skin Sciences Reports Strong Q4 Growth and Strategic Progress - MSN
Strata Skin Sciences Inc. (SSKN) reports earnings - Quartz
STRATA Skin Sciences Reports Growth Amid Strategic Shifts - TipRanks
Earnings call transcript: STRATA Skin Sciences Q4 2024 revenue rises 10% By Investing.com - Investing.com South Africa
Earnings call transcript: STRATA Skin Sciences Q4 2024 revenue rises 10% - Investing.com India
STRATA Skin Sciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides a Corporate Update - GlobeNewswire
STRATA Skin Sciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Strata Skin Sciences Reports Q4 2024 Financial Results - TipRanks
STRATA SKIN SCIENCES Earnings Results: $SSKN Reports Quarterly Earnings - Nasdaq
Earnings Preview For Strata Skin Sciences - Benzinga
STRATA Skin Sciences Inc expected to post a loss of 30 cents a shareEarnings Preview - TradingView
STRATA SKIN SCIENCES Earnings Preview: Recent $SSKN Insider Trading, Hedge Fund Activity, and More - Nasdaq
STRATA Skin Sciences to Announce Year-End Financial Results - MSN
STRATA Skin Sciences to Report Fourth Quarter and Year End - GlobeNewswire
STRATA Skin Sciences to Report Fourth Quarter and Year End 2024 Financial Results on March 27, 2025 and Provide Corporate Update - The Manila Times
STRATA Skin Sciences, Inc. to Report Fourth Quarter and Year End 2024 Financial Results on March 27, 2025 - Nasdaq
STRATA Skin Sciences Year-End Earnings and Strategic Update: Key Details for Investors - StockTitan
Study Validates Advantages of STRATA Skin Sciences’ XTRAC Laser Technology - MyChesCo
Excimer laser outperforms in dermatologic study - Investing.com India
Strata Skin Sciences Highlights XTRAC® Laser Study Success - TipRanks
Identity, Access Management & Biometric Solutions Provider BIO-key International Hosts Q4 Investor Call Thursday, March 27th at 10am ET - The Manila Times
STRATA Skin Sciences Highlights Study Validating Superior Efficacy of XTRAC® Excimer Laser Technology for Dermatologic Treatments - Nasdaq
STRATA Skin Sciences Highlights New Clinical Study from - GlobeNewswire
Breakthrough Study: STRATA's XTRAC Laser Outperforms Competitors in Treating Skin Conditions - Stock Titan
VYNE Therapeutics to Participate in the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference - The Manila Times
STRATA Skin Sciences (SSKN) Projected to Post Earnings on Wednesday - Defense World
Canada's new leader announces $4.2 billion Australian radar purchase on visit to Arctic Circle - The Globe and Mail
Hair Removal Devices Market Edition 2025: Global Industry Size - openPR
Hogs Close Higher in the Front Months on Friday - The Globe and Mail
AECOM named Official Venue Infrastructure Partner for the Los Angeles 2028 Olympic and Paralympic Games - The Globe and Mail
STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Short Interest Up 183.3% in February - Defense World
Professional Diversity Network (NASDAQ:IPDN) Now Covered by Analysts at StockNews.com - Defense World
Facial Rejuvenation Market Poised for Substantial Growth from - openPR
STRATA Skin Sciences, Inc. to Host Earnings Call - ACCESS Newswire
STRATA Skin Sciences CEO to Present at Benchmark’s 13th Annual Discovery Investor Conference - MSN
CorMedix Inc. Announces New Appointments to Senior Leadership Team - ACCESS Newswire
Maxim Group Initiates Coverage on STRATA Skin Sciences (NASDAQ:SSKN) - Defense World
STRATA Skin Sciences (NASDAQ:SSKN) Now Covered by Analysts at Maxim Group - Armenian Reporter
USANA Health Sciences (NYSE:USNA) Reaches New 52-Week Low After Analyst Downgrade - Defense World
Skin Rejuvenation Market Size, Share And Trends Report, 2033 - WICZ
Maxim Group Initiates Coverage of STRATA Skin Sciences (SSKN) with Buy Recommendation - Nasdaq
Hair Removal Devices Market Size, Regional Outlook, Valuable - openPR
Allworth Financial LP Increases Position in Danaos Co. (NYSE:DAC) - Defense World
Hair Removal Devices Market Size & Share Analysis 2024-2032 - WICZ
Investor Network: STRATA Skin Sciences, Inc. to Host Earnings Call - ACCESS Newswire
Rhumbline Advisers Decreases Position in DaVita Inc. (NYSE:DVA) - Defense World
Photo Rejuvenation Devices Market Market Future Business - openPR
Key Driver Transforming The Non-Surgical Cosmetic Procedures Market 2025: Trends Boost Market Growth - EIN News
Strata Skin Sciences Inc (SSKN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Strata Skin Sciences Inc 주식 (SSKN) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Accelmed Partners, L.P. | 10% Owner |
Jul 15 '24 |
Buy |
3.14 |
230,573 |
723,999 |
1,441,835 |
| Rafaeli Dolev | Chief Executive Officer |
Jul 15 '24 |
Buy |
3.14 |
19,100 |
59,974 |
143,156 |
0.69%
0.15%
자본화:
|
볼륨(24시간):